SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Plasma is the layer 1 blockchain building the stablecoin infrastructure for a new global financial system.   It is purpose-built for global stablecoin payments, offering zero-fee USD₮ transfers and custom gas tokens to help realise the stablecoin promise of permissionless access to financial services for everyone, everywhere.   Plasma’s global payments coverage and inbound suite of products position it as the native chain for stablecoin payments.

Plasma

Plasma (XPL) is actively discussed following recent exchange listings and an Alchemy Pay integration enabling fiat on-ramps, positioning it as a zero-fee stablecoin transfer layer. However, community sentiment is sharply divided, with bulls touting its potential utility and long-term value, while bears point to significant price depreciation and concerns over token unlocks, labeling it a 'scam' or 'pump and dump'.

GRAIL, Inc. operates as a commercial-stage healthcare company, which engages in the development of a technology for early detection of cancer. It utilizes machine learning, software, and automation to detect and identify multiple deadly cancer types in earlier stages. The company was founded by Jeffrey T. Huber, William H. Rastetter, Mostafa Ronaghi, and Richard D. Klausner on September 11, 2015 and is headquartered in Menlo Park, CA.

GRAIL Inc.

GRAIL is trending as it moves closer to FDA approval for its Galleri multi-cancer early detection test, bolstered by strong PATHFINDER 2 study results and strategic partnerships with Samsung and Hims & Hers for broader market access. The community is actively discussing the potential for Medicare reimbursement through recently advanced legislation, viewing this as a monumental step towards unlocking a vast market for early cancer diagnostics.

Propy is a decentralized real-estate market place backed by superior blockchain infrastructure to facilitate real-time unified transaction in order to reduce fraud and redundancy. Propy is the world’s first international real-estate marketplace.

Propy

Propy is trending as the community highlights its AI agent, Avery, and the disruptive potential of real estate tokenization within the Real World Asset (RWA) sector. Conversations are centered on its innovative use of blockchain and AI to streamline property transactions and enhance transparency.

Bitcoin Cash is a hard fork of Bitcoin with a protocol upgrade to fix on-chain capacity. Bitcoin Cash intends to be a Bitcoin without Segregated Witness (SegWit) as soft fork, where upgrades of the protocol are done mainly through hard forks and without changing the original economic rules of the Bitcoin.  Bitcoin Cash (BCH) is released on 1st August 2017 as an upgraded version of the original Bitcoin Core software. The main upgrade is the increase in the block size limit from 1MB to 8MB. This effectively allows miners on the BCH chain to process up to 8 times more payments per second in comparison to Bitcoin. This makes for faster, cheaper transactions and a much smoother user experience.  Why was Bitcoin Cash Created?  The main objective of Bitcoin Cash is to to bring back the essential qualities of money inherent in the original Bitcoin software. Over the years, these qualities were filtered out of Bitcoin Core and progress was stifled by various people, organizations, and companies involved in Bitcoin protocol development. The result is that Bitcoin Core is currently unusable as money due to increasingly high fees per transactions and transfer times taking hours to complete. This is all because of the 1MB limitation of Bitcoin Core’s block size, causing it unable to accommodate to large number of transactions.  Essentially Bitcoin Cash is a community-activated upgrade (otherwise known as a hard fork) of Bitcoin that increased the block size to 8MB, solving the scaling issues that plague Bitcoin Core today.  Nov 16th 2018: A hashwar resulted in a split between Bitcoin SV and Bitcoin ABC

Bitcoin Cash

Bitcoin Cash is drawing significant attention as MF International announced plans for BCH self-mining and the upcoming May 2026 CashVM upgrade aims to significantly enhance its programmability and utility. The community is actively discussing BCH's notable outperformance against Bitcoin year-to-date and its perceived resilience as a leader, fueling speculation about a major technical breakout and its role as a peer-to-peer electronic cash system.

Ocular Therapeutix, Inc. is a biopharmaceutical company, which engages in the development and commercialization of therapies for diseases and conditions of the eye. Its product pipeline includes Dextenza, OTX-TP, and OTX-TIC. The company was founded by Amarpreet S. Sawhney and Farhad Khosravi on September 12, 2006 and is headquartered in Bedford, MA.

Ocular Therapeutix Inc

Ocular Therapeutix is surging on high anticipation for its imminent SOL-1 Phase 3 superiority trial data for wet AMD, with the community actively discussing potential blockbuster results and renewed Sanofi buyout speculation to drive a significant valuation increase.

ShapeShift is a decentralized, multichain cryptocurrency platform that empowers users to swap, track, buy, and earn with over 30,000 assets across the top blockchains such as Bitcoin, Ethereum, Dogecoin, Cosmos, and more. The platform emphasizes financial sovereignty and self-custody, providing an open-source environment where users can engage with the most popular crypto tools and services to trade, earn, and hodl their digital assets. FOX token holders can submit and vote on proposals, helping to shape the future of ShapeShift.

ShapeShift FOX Token

FOX CRYPTO is gaining attention as investors believe the ShapeShift FOX Token is significantly undervalued with a low market cap compared to its DeFi competitors. The community is actively discussing its technical setup, anticipating an imminent breakout from a prolonged downtrend that could lead to a substantial rally as alt season approaches.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is currently trending as the community eagerly anticipates imminent PMDA approval in Japan and celebrates successful glioblastoma patient treatment updates, fueling strong bullish sentiment and institutional accumulation for its Alpha DaRT oncology technology.

Direxion Shares ETF Trust - Direxion Daily South Korea Bull 3X Shares

Direxion Daily South Korea Bull 3X Shares

Direxion Daily South Korea Bull 3X Shares ($KORU) is experiencing a massive surge following South Korea's recent ban on short selling, intensifying its already impressive year-to-date rally fueled by semiconductor giants like Samsung and SK Hynix in the booming memory market.

Function is building the financial infrastructure that makes Bitcoin productive, unlocking yield, liquidity, and capital efficiency for holders across DeFi and traditional finance. FBTC turns Bitcoin into an asset that works.  FBTC represents the first omnichain Bitcoin yield asset, enabling BTC holders to participate in structured, risk-managed and programmatic yield strategies. FBTC is fully backed on a 1:1 basis with BTC, Bitcoin Reserve Address List is public and can be verified at any time. FBTC combines the security of Bitcoin reserves with the flexibility of smart contracts, creating a secure and efficient bridge between the Bitcoin network and modern DeFi protocols.  FBTC turns idle BTC into a functional and productive asset. The primary purpose of FBTC is to bring native Bitcoin liquidity into DeFi. Enabling Bitcoin holders to access a wide range of yield generating strategies, without having to sell their BTC. This not only enhances the utility of BTC but also allows holders to earn returns on their assets, making FBTC a powerful tool for maximizing the potential of Bitcoin in the DeFi ecosystem

Function ƒBTC

Fidelity's FBTC is a key focus amidst a turbulent period for spot Bitcoin ETFs, which are seeing considerable outflows, though FBTC has notably registered some small inflows. Community discussion is polarized, with some attributing volatility to ETF activity while others view institutional participation, like FBTC, as foundational to Bitcoin's long-term valuation.

Arcturus Therapeutics Holdings, Inc. operates as a late-stage clinical mRNA medicines and vaccine company, which engages in the development of infectious disease vaccines and significant opportunities within liver and respiratory rare diseases. Its products include LUNAR-COV19, LUNAR-FLU, LUNAR-OTC, and LUNAR-CF. The company was founded in 2013 and is headquartered in San Diego, CA.

Arcturus Therapeutics Holdings Inc

Arcturus Therapeutics is drawing intense community discussion and market volatility following its mixed interim Phase 2 data for the ARCT-032 cystic fibrosis therapy, as investors also closely monitor ongoing developments in its trade secret lawsuit and progress across its broader mRNA pipeline.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Radius Recycling (RDUS) Reports Q3 Loss, Beats Revenue Estimates

Radius Recycling (RDUS) delivered earnings and revenue surprises of +55.17% and +7.38%, respectively, for the quarter ended May 2025. Do the numbers hold clues to what lies ahead for the stock?

Radius Recycling, Inc. engages in the recycling of ferrous and nonferrous scrap metal and manufacture of finished steel products. The company was founded by Sam Schnitzer in 1906 and is headquartered in Portland, OR.

Radius Recycling Inc. - Ordinary Shares - Class A

3%+ above current levels

Up 0–3%

Flat to down 3%

Down 3%+

The Nasdaq 100 continues to hinge on mega-cap tech and AI strength. With rate expectations shifting and valuations stretched, even a 3% move could signal a bigger trend. Is momentum building, or fading?

RDUS
Radius Recycling

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest RDUS News

RDUSRadius Recycling